Texas Oncology-Austin Midtown — Austin, Texas

Texas Oncology-Austin Midtown is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Texas Oncology-Austin Midtown has participated in 38 clinical trials with 13 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma.

Sponsors: Gilead Sciences, NRG Oncology, Loxo Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Austin Midtown?

Texas Oncology-Austin Midtown has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Austin Midtown conducted?

Texas Oncology-Austin Midtown has 38 clinical trials on record, with 13 currently active. Their work covers Chronic Lymphocytic Leukemia, Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma.

Is Texas Oncology-Austin Midtown accredited by Crixeo Health?

Yes — Texas Oncology-Austin Midtown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Austin Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.